Gluconeogenesis combats cancer: opening new doors in cancer biology.
about
Nur77 suppresses hepatocellular carcinoma via switching glucose metabolism toward gluconeogenesis through attenuating phosphoenolpyruvate carboxykinase sumoylation.The anti-angiogenic effect of dexamethasone in a murine hepatocellular carcinoma model by augmentation of gluconeogenesis pathway in malignant cells.High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cellsComprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers
P2860
Gluconeogenesis combats cancer: opening new doors in cancer biology.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@en
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@nl
type
label
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@en
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@nl
prefLabel
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@en
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@nl
P2860
P356
P1476
Gluconeogenesis combats cancer: opening new doors in cancer biology.
@en
P2093
P Chakrabarti
P2860
P356
10.1038/CDDIS.2015.245
P50
P577
2015-09-03T00:00:00Z